Sphera Funds Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.73M	Buy	243,575 +3,811	+2%	+$104K	1.33%	22
2025 Q4	$6.51M	Buy	239,764 +32,000	+15%	+$843K	1.36%	29
2025 Q3	$5.37M	Sell	207,764 -211,776	-50%	-$4.91M	1.27%	27
2025 Q2	$8.54M	Sell	419,540 -88,289	-17%	-$1.72M	2.23%	12
2025 Q1	$9.22M	Buy	507,829 +33,726	+7%	+$754K	2.27%	11
2024 Q4	$12M	Buy	474,103 +55,000	+13%	+$1.49M	2.21%	10
2024 Q3	$14.2M	Buy	419,103 +109,838	+36%	+$4.19M	2.33%	10
2024 Q2	$11.4M	Buy	309,265 +32,269	+12%	+$1.22M	1.87%	19
2024 Q1	$11.6M	Sell	276,996 -38,648	-12%	-$1.59M	1.88%	18
2023 Q4	$12.5M	Buy	315,644 +135,644	+75%	+$3.99M	2.32%	11
2023 Q3	$4.95M	Buy	180,000 +20,000	+13%	+$627K	1.19%	39
2023 Q2	$5.43M	Buy	+160,000	New	+$5.39M	1.16%	47
2022 Q1	–	Sell	-166,766	Closed	-$6.44M	–	77
2021 Q4	$6.44M	Buy	166,766 +36,436	+28%	+$1.59M	0.77%	48
2021 Q3	$7.04M	Buy	+130,330	New	+$6.12M	0.7%	52
2021 Q2	–	Sell	-220,320	Closed	-$4.54M	–	142
2021 Q1	$4.54M	Sell	220,320 -376,878	-63%	-$8.65M	0.42%	75
2020 Q4	$10.5M	Buy	597,198 +227,198	+61%	+$4.09M	1.09%	31
2020 Q3	$5.49M	Buy	+370,000	New	+$4.33M	0.64%	54
2015 Q2	–	Sell	-7,000	Closed	-$2.93M	–	139
2015 Q1	$2.93M	Buy	+7,000	New	+$2.5M	0.42%	83